Linked Life Data

12795103

Source:http://linkedlifedata.com/resource/pubmed/id/12795103

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12795103rdf:typepubmed:Citationlld:pubmed
pubmed-article:12795103lifeskim:mentionsumls-concept:C0025344lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C0017118lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C0024623lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C0221198lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C1609982lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C0449438lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C2347804lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C1561960lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C1948053lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C1172402lld:lifeskim
pubmed-article:12795103lifeskim:mentionsumls-concept:C2828372lld:lifeskim
pubmed-article:12795103pubmed:issue5lld:pubmed
pubmed-article:12795103pubmed:dateCreated2003-6-10lld:pubmed
pubmed-article:12795103pubmed:abstractTextA 71-year-old man with nausea and epigastralgia was referred to our hospital and was diagnosed with type 3 gastric cancer. Palliative resection was performed since radical surgery was impossible due to massive tumorous invasion to the retroperitoneum. Chemotherapy with TS-1 100 mg p.o. was started for the residual cancer lesions, with CDDP i.v. 50 mg added from the 3rd course. We did not find any remarkable side effects except for grade 1 loss of appetite. This chemotherapy was ended after the eighth course. The residual tumor did not disappear but did not grow, and a no change status was maintained for twelve months after the gastrectomy.lld:pubmed
pubmed-article:12795103pubmed:languagejpnlld:pubmed
pubmed-article:12795103pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12795103pubmed:citationSubsetIMlld:pubmed
pubmed-article:12795103pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12795103pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12795103pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12795103pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12795103pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12795103pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12795103pubmed:statusMEDLINElld:pubmed
pubmed-article:12795103pubmed:monthMaylld:pubmed
pubmed-article:12795103pubmed:issn0385-0684lld:pubmed
pubmed-article:12795103pubmed:authorpubmed-author:HasegawaShige...lld:pubmed
pubmed-article:12795103pubmed:authorpubmed-author:NakamuraYasuk...lld:pubmed
pubmed-article:12795103pubmed:authorpubmed-author:SakuraiYoichi...lld:pubmed
pubmed-article:12795103pubmed:authorpubmed-author:MatsubaraTosh...lld:pubmed
pubmed-article:12795103pubmed:authorpubmed-author:ImazuHirokiHlld:pubmed
pubmed-article:12795103pubmed:authorpubmed-author:OchiaiMasahir...lld:pubmed
pubmed-article:12795103pubmed:authorpubmed-author:NozoeYasutomo...lld:pubmed
pubmed-article:12795103pubmed:authorpubmed-author:SakaiWakanaWlld:pubmed
pubmed-article:12795103pubmed:authorpubmed-author:YoshidaIkuoIlld:pubmed
pubmed-article:12795103pubmed:authorpubmed-author:TonomuraShuhe...lld:pubmed
pubmed-article:12795103pubmed:issnTypePrintlld:pubmed
pubmed-article:12795103pubmed:volume30lld:pubmed
pubmed-article:12795103pubmed:ownerNLMlld:pubmed
pubmed-article:12795103pubmed:authorsCompleteYlld:pubmed
pubmed-article:12795103pubmed:pagination691-3lld:pubmed
pubmed-article:12795103pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:meshHeadingpubmed-meshheading:12795103...lld:pubmed
pubmed-article:12795103pubmed:year2003lld:pubmed
pubmed-article:12795103pubmed:articleTitle[Sustained NC status for a long period after combined chemotherapy of TS-1 and CDDP for residual lesions following gastrectomy for gastric cancer].lld:pubmed
pubmed-article:12795103pubmed:affiliationDept. of Surgery, Fujita Health University, School of Medicine.lld:pubmed
pubmed-article:12795103pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12795103pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:12795103pubmed:publicationTypeCase Reportslld:pubmed